FDA Person
FDADamaris Y. Hernandez
View detailed information about Damaris Y. Hernandez, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 31 inspections of 31 companies, 2023–2026.
Inspections (31)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 18, 2026 | KM PHARMACEUTICAL CO., LTD. | Not classified | #1342994 | |
| September 11, 2026 | Outin Futures Corp | Not classified | Drug Quality Assurance | #1335548 |
| September 4, 2026 | Kolon Life Science Inc. - Chungju Plant | Not classified | #1340126 | |
| July 31, 2026 | Aizant Drug Research Solutions Private Ltd. | Not classified | Drug Quality Assurance | #1328790 |
| July 21, 2026 | Curia India Private Limited | Not classified | #1330244 | |
| March 20, 2026 | Bausch & Lomb Incorporated | Not classified | #1304548 | |
| January 30, 2026 | Catalent Pharma Solutions, LLC | Not classified | #1282788 | |
| November 21, 2025 | KRS PHARMACEUTICALS PRIVATE LIMITED | Not classified | #1296522 | |
| November 14, 2025 | Dr. Reddy's Laboratories Ltd | Not classified | #1296480 | |
| November 7, 2025 | Tianish Laboratories Private Limited | Not classified | #1290824 | |
| September 18, 2025 | Immacule Lifesciences Private Limited | OAI | Monitoring of Marketed Animal Drugs, Feed, and Devices | #1286150 |
| September 5, 2025 | Zydus Lifesciences Limited | Not classified | #1282790 | |
| June 17, 2025 | Glenmark Pharmaceuticals Inc USA | Not classified | Drug Quality Assurance | #1267093 |
| April 24, 2025 | Absolutely Natural | OAI | Drug Quality Assurance | #1250751 |
| March 20, 2025 | Pharmco Laboratories Inc. | VAI | Drug Quality Assurance | #1231002 |
| February 7, 2025 | Hospira, Inc. | Not classified | #1251941 | |
| November 22, 2024 | Ercros S.A. | Not classified | #1256356 | |
| November 12, 2024 | Torbay Pharmaceuticals Ltd. | Not classified | #1256289 | |
| September 20, 2024 | Salon Technologies International, Inc | VAI | Drug Quality Assurance | #1249648 |
| August 2, 2024 | AHC LTD. | VAI | Drug Quality Assurance | #1247042 |
Documents (24)
- EIR · QuVa Pharma, Inc. · June 16, 2022
- 483 · KRS PHARMACEUTICALS PRIVATE LIMITED · November 21, 2025
- 483 · Zydus Lifesciences Limited · February 8, 2024
- 483 · Immacule Lifesciences Private Limited · September 18, 2025
- 483 · Tarmac Products, Inc. · July 22, 2022
- 483 · Catalent Pharma Solutions, LLC · January 30, 2026
- 483 · Tianish Laboratories Private Limited · November 7, 2025
- 483 · Zydus Lifesciences Limited · September 5, 2025
- 483 · Torbay Pharmaceuticals Ltd. · November 12, 2024
- 483 · Pharmco Laboratories Inc. · March 20, 2025
- 483 · Ercros S.A. · November 22, 2024
- 483 · Uniao Quimica Farmaceutica Nacional SA · August 9, 2023
- 483 · Chemco Corporation · October 31, 2022
- 483 · Hospira, Inc., A Pfizer Company · June 30, 2023
- 483 · PAI Holdings, LLC, dba Pharmaceutical Associates, Inc · September 2, 2022
- 483 · Klocke of America, Inc. · March 30, 2022
- 483 · Ultrum Labs LLC · October 16, 2023
- 483 · Absolutely Natural · April 24, 2025
- 483 · Natural Technology LLC · March 1, 2024
- 483 · QuVa Pharma, Inc. · June 16, 2022
- 483 · Glenmark Pharmaceuticals Inc USA · June 17, 2025
- 483 · Torbay Pharmaceuticals, Ltd. · November 12, 2024
- 483 · Samchundang Pharm Co., Ltd. · May 19, 2026
- 483 · Aizant Drug Research Solutions Private Ltd. · July 31, 2026
Frequently inspected with (10)
Person Information
Name
Damaris Y. Hernandez
Role
INVESTIGATOR
ID: ca16093e-047b-4bf1-bcc1-c439cff21e8a
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.